Prospective Multi-Institutional Study of Definitive Radiotherapy With High-Dose-Rate Intracavitary Brachytherapy in Patients With Nonbulky (<4-cm) Stage I and II Uterine Cervical Cancer (JAROG0401/JROSG04-2)

Article ID	Journal	Published Year	Pages	File Type
8228208	International Journal of Radiation OncologyBiologyPhysics	2012	8 Pages	PDF

Abstract

These results suggest that definitive radiotherapy using HDR-ICBT with a low cumulative dose schedule (BED, 62 Gy10 at point A) can provide excellent local control without severe toxicity in nonbulky (<4-cm) early-stage cervical cancer.

Keywords

Intracavitary brachytherapy Radiotherapy Carcinoma of the cervix High-dose-rate Dose response

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

Prospective Multi-Institutional Study of Definitive Radiotherapy With High-Dose-Rate Intracavitary Brachytherapy in Patients With Nonbulky (<4-cm) Stage I and II Uterine Cervical Cancer (JAROG0401/JROSG04-2)

Authors

Takafumi M.D., Ph.D., Shingo M.D., Ph.D., Yuzuru M.D., Ph.D., Tatsuya M.D., Ph.D., Tomoko M.D., Ph.D., Takeshi M.D., Ph.D., Masaaki M.D., Ph.D., Naoto M.D., Ph.D., Masahiro M.D., Ph.D., Sunao M.D., Chikako M.D., Ph.D., Osamu M.D., Ph.D., Hideyuki M.D.,